title: Coenzyme Q10 in neuromuscular and neurodegenerative disorders.
abstract: Coenzyme Q10 (CoQ10, or ubiquinone) is an electron carrier of the mitochondrial respiratory chain (electron transport chain) with antioxidant properties. In view of the involvement of CoQ10 in oxidative phosphorylation and cellular antioxidant protection a deficiency in this quinone would be expected to contribute to disease pathophysiology by causing a failure in energy metabolism and antioxidant status. Indeed, a deficit in CoQ10 status has been determined in a number of neuromuscular and neurodegenerative disorders. Primary disorders of CoQ10 biosynthesis are potentially treatable conditions and therefore a high degree of clinical awareness about this condition is essential. A secondary loss of CoQ10 status following HMG-Coa reductase inhibitor (statins) treatment has be implicated in the pathophysiology of the myotoxicity associated with this pharmacotherapy. CoQ10 and its analogue, idebenone, have been widely used in the treatment of neurodegenerative and neuromuscular disorders. These compounds could potentially play a role in the treatment of mitochondrial disorders, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, Friedreich's ataxia, and other conditions which have been linked to mitochondrial dysfunction. This article reviews the physiological roles of CoQ10, as well as the rationale and the role in clinical practice of CoQ10 supplementation in different neurological and muscular diseases, from primary CoQ10 deficiency to neurodegenerative disorders. We also briefly report a case of the myopathic form of CoQ10 deficiency.
authors.affiliation: Department of Neuroscience, Neurological Clinic, University of Pisa, Italy. mmancuso@inwind.it
authors.forename: M
authors.initials: M
authors.lastname: Mancuso
authors.forename: D
authors.initials: D
authors.lastname: Orsucci
authors.forename: L
authors.initials: L
authors.lastname: Volpi
authors.forename: V
authors.initials: V
authors.lastname: Calsolaro
authors.forename: G
authors.initials: G
authors.lastname: Siciliano
mesh_terms: D000818:Animals; D006801:Humans; D028361:Mitochondrial Diseases / Q000188:drug therapy / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000378:metabolism*; D009468:Neuromuscular Diseases / Q000188:drug therapy* / Q000378:metabolism*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000172:deficiency / Q000502:physiology / Q000627:therapeutic use
chemical_list: D014451:Ubiquinone; C024989:coenzyme Q10; C036619:idebenone